Chronic pain management: interdisciplinary care, activity as medicine, and when to avoid surgery
A GP-facing summary of a pain-specialist CPD talk that follows Neil Cochrane’s surgery-expectations lecture — nociception vs lived pain, biopsychosocial team care, opioids and cannabinoids caveats, radiofrequency as a stepping stone, and spinal stimulation as a “volume control” after a trial.
- Primary speaker
- Richard (surname not clearly captured in Otter transcript) — pain specialist. Host welcomes “Richard”; closing thanks “Neil and Richard and Carl”. Speaks as implanting/taking over SCS care and using RF/injection procedures diagnostically.
- Panel / Q&A
- Dr Neil Cochrane (neurosurgeon, preceding talk) — emphasises spending the day avoiding operations (~5% conversion cited vs bosses who convert ~30%); allied-health-rich practice. Audience GPs on psychology framing and RF role. Abbott team present from earlier segment.
- Session context
- Otter id
V0oNhpBS_RfAFLmFUIGOGSl0CPY· title Chronic Pain Management Seminar · ~83.0 min (4980 s) · recorded evening 2026-02-19 after the spinal-surgery talk. Substantial end-of-file social/ASR bleed (fasting chat, parking, etc.) is ignored. ASR imperfect — drug names (e.g. tapentadol), study claims and device details should be checked.
Key messages for GPs
- Nociception is the physiological signalling; chronic pain is the lived, multi-domain consequence — sleep, work, isolation, medication dependence.
- Contemporary care is interdisciplinary: no single injection, surgery, physio or tablet fixes established chronic pain alone.
- Judge success by function and life roles, not only the 0–10 score — people can still rate 8–10 yet return to work and family.
- Rule of thumb: manage chronic pain without opioids — not dogma; if used, prefer atypical agents (talk lists tapentadol, tramadol, buprenorphine) and avoid fentanyl / oxycodone / morphine patterns; trial and oversee.
- Cannabinoids: booming for pain, anxiety, sleep — but speaker flags weak regulation/oversight and a thin evidence base relative to industry scale; some patients do well.
- Activity beats opioids, cannabinoids, surgery, injections and even stimulators — if you can get the patient moving with a therapist who promotes exercise, not only passive massage/needling.
- RF and SCS are tools to enable activity — RF as a stepping stone, not a three-monthly churn; SCS after a trial, framed as volume control not cure.
Nociception vs pain and the biopsychosocial model
Descartes-era diagrams of a fire under the foot and a signal to the brain still capture the pipeline — but we now call that pipeline nociception, with modern detail on neurotransmitters, processing and neuroplasticity. Anatomical back-pain generators (Neil’s list) explain short-term and some ongoing pain; many clinic patients layer a broader chronic pain condition on top.
Phases: injury/aggravation → inflammation → changed nerve behaviour. Consequence is wider than “it hurts here this much”: impaired function and sleep, isolation from work and social life, medical triathlon and medication dependence. Hence the biopsychosocial (or social-psycho-bio) model — multi-facet problem needs a multi-facet team. Surgery and stimulators can play a role inside that picture, not as solo cures.
Measuring success: function over the 0–10 score
The 0–10 scale has vague use. Better success metric: day-to-day function and life roles. Someone can stay at 8–10 yet move from couch-bound to working and engaged with less medication — that is a different clinical world. Getting there takes hard work, mostly from within, with support.
Why avoid surgery (often)
Many referred patients have anatomical generators plus nociplastic / widespread pain. Fixing one focal generator surgically may leave most of the pain map untouched. Neil likely spends more time finding non-operative paths than selling operations — and “I’ve tried everything” often means incomplete trials when you drill down. Beautiful multi-level fusion hardware can stabilise perfectly and still leave pain. Disc bulge with neuropathic pain can settle over months by natural history. Less invasive options exist before the knife. Education must reset the “fifth decade and suddenly crippled — why can’t you fix me?” expectation: sometimes the best is good management, not cure.
Fragmented advice (surgeon vs physio vs “Dr Google”) exhausts GPs and patients. Aim: surgeons, pain specialists, neurologists, physios and psychologists speaking one recovery language.
Medications: opioids and cannabinoids
No single medicine fits all. Caution — medicines cause harm.
| Topic | Talk framing for GPs |
|---|---|
| Opioids | Rule of thumb: chronic pain without opioids. Not absolute dogma — judicious atypical opioids (tapentadol, tramadol, buprenorphine cited) with oversight; avoid fentanyl, oxycodone, morphine patterns for long-term chronic non-cancer use. Correlation between strong-opioid volume and prescription-opioid deaths noted; Australian heat-map less extreme than North America but history matters. Under-prescribing in palliative cancer settings elsewhere is also harm. |
| Cannabinoids | Surge for chronic pain, anxiety, sleep. Two problems: lack of meaningful regulatory oversight (poor data on who is on what, side effects, start/stop) and thin peer-reviewed evidence relative to a huge global industry. Speaker is not anti-cannabinoid — some patients do very well — but wants oversight and evidence. |
Activity is the best medicine
Best medicine = activity — framed as better than any opioid, cannabinoid, surgery, injection or stimulator. Needs education, motivation, pain control to start, and a physical therapist (physio, EP, myotherapist — “I don’t care which”) who promotes activity. Passive-only deep-tissue massage / dry needling may feel nice for 24 hours but will not change capacity if exercise is missing.
Injection procedures and radiofrequency
Richard uses injections ~half to one day per week for diagnosis and to help people get active — nerve blocks, joint injections, radiofrequency. RF can quiet an aggravated facet for ~a year to reopen rehab — not as isolated three-monthly churn. Default is: do it well once, get them active, set them free; occasional repeat, not the plan.
Q&A detail — two RF situations:
- Established facet pathology — mechanical pain matching degenerative facets; diagnostic local anaesthetic response even if steroid “didn’t fix me”; then RF denervation (uni/bilateral, adjacent levels). Common levels cited: L4/5, L5/S1; cervical C4/5, C5/6.
- Established neuralgia — e.g. L5/S1 disc catching L5, good but non-durable nerve injection, surgeon prefers to defer decompression in a younger adult → pulsed RF as bridge for brachialgia/sciatica.
Spinal stimulation as volume control
Negative media exists; some patients are harmed — as with any invasive care. Missing from headlines: thousands who do well. Majority manage pain better, improve function, reduce meds; few are cured; non-responders may explant. Serious complications rare but not zero. Technique: epidural leads, IPG, low-level stimulation suppressing unhelpful pain signalling — “pacemaker for pain” / noise-cancelling headphones framing, not a TENS implant. Trial first; no durable benefit → do not implant.
Useful niches cited: persistent pain after good-faith spinal surgery with no further surgical target; CRPS (many respond); post-surgical neuropathic pain (thoracotomy, mastectomy, hip/knee); some phantom limb pain. If revision surgery is still indicated, send back to the surgeon — do not stim over an unfixed structural problem.
Team messaging and psychology
Neil (Q&A): aims to convert ~5% of new patients to surgery (vs bosses who aimed ~30%), using allied-health-rich practice and Richard’s pain pathway. Reverse benefit: surgeon saying “you do not need an operation” unlocks lifestyle engagement that patients resisted while still hoping for a surgical fix. Audience: fear of movement (“someone said my back is both — ASR”) and psychology referrals sounding like “you’re imagining it”. Richard’s reframe: look stunned they don’t have a psychologist — of course they are suffering — which often opens acceptance.
Q&A highlights
- Foot drop timing: Neil — dense/complete foot drop needs prompt specialist review (medico-legal and recovery); incomplete with improving power can be watched closely. NCS at 2–3 months often unhelpful early; clinical density and week-to-week trend matter more; later consider common peroneal neuropathy in the differential.
- Education topics for patients: condition literacy, mindset/mental health, movement, nutrition, medication awareness, personalised plans, community/work connection.